Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 6/20 | 0.61 |
| ▸ | HPGD | P15428 | 3/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.57 |
| ▸ | NPC1 | O15118 | 3/20 | 0.56 |
| ▸ | RAB9A | P51151 | 3/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.56 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.50 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.50 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.50 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.50 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23475863 | 1.00 | EPHX1 (0.61) | EPHX1HPGDKMT2ASMN1; SMN2ALDH1A1 | |
| SCHEMBL23475876 | 1.00 | EPHX1 (0.61) | EPHX1HPGDKMT2ASMN1; SMN2ALDH1A1 | |
| SCHEMBL22546754 | 1.00 | EPHX1 (0.61) | EPHX1HPGDKMT2ASMN1; SMN2ALDH1A1 | |
| Hydrochloric Acid SCHEMBL7307604 | 0.98 | EPHX1 (0.59) | EPHX1HPGDKMT2ASMN1; SMN2ALDH1A1 | |
| SCHEMBL991938 | 0.98 | SMN1; SMN2 (0.61) | EPHX1HPGDKMT2ASMN1; SMN2ALDH1A1 | |
| Hydrochloric Acid SCHEMBL3512220 | 0.95 | SMN1; SMN2 (0.59) | EPHX1HPGDKMT2ASMN1; SMN2ALDH1A1 | |
| SCHEMBL31723928 | 0.93 | — | — | |
| SCHEMBL3135300 | 0.88 | — | — | |
| SCHEMBL16853215 | 0.88 | SMN1; SMN2 (0.48) | EPHX1HPGDKMT2ASMN1; SMN2ALDH1A1 | |
| Hydrochloric Acid SCHEMBL1996186 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2385948-B1 | FUSED THIAZOLO AND OXAZOLO PYRIMIDINONES | TORRENT PHARMACEUTICALS LTD (IN) | 2017-10-04 | — | — | EP | claimed |
| WO-2011008915-A1 | PYRROLOPYRIDINE INHIBITORS OF KINASES | ABBOTT LABORATORIES (US) | 2011-01-20 | — | — | WO | claimed |
| CN-119875056-A | Polyurea material and supercritical foaming composite midsole | 福建鑫瑞新材料科技有限公司 | 2025-04-25 | — | — | CN | disclosed |
| US-11339128-B2 | Substituted 4-amino-5-(cyclohexyloxy)quinoline-3-carboxylic acids as sweet flavor modifiers | FIRMENICH INCORPORATED (US) | 2022-05-24 | — | — | US | disclosed |
| CN-113430595-A | Method for plating copper on surface of brass casting | 惠州市安泰普表面处理科技有限公司 | 2021-09-24 | — | — | CN | disclosed |
| EP-3096751-B1 | 12-EPI-PLEUROMUTILINS | Nabriva Therapeutics GmbH (AT) | 2021-01-06 | — | — | EP | disclosed |
| CN-104962221-B | A kind of glass curtain wall structure sealant and preparation method thereof | 香山红叶建设有限公司 | 2018-07-13 | — | — | CN | disclosed |
| WO-2017005073-A1 | STRUCTURAL SEALANT FOR GLASS CURTAIN WALL AND PREPARATION METHOD THEREFOR | 梁怡芃 | 2017-01-12 | — | — | WO | disclosed |
| CN-104927727-B | Structural sealant for glass curtain walls and preparation method for structural sealant | 香山红叶建设有限公司 | 2017-01-11 | — | — | CN | disclosed |
| CN-104962221-A | Structural sealant for glass curtain wall and preparation method for structural sealant | Shandong xiangshan decoration engineering co ltd | 2015-10-07 | — | — | CN | disclosed |
| CN-104927727-A | Structural sealant for glass curtain walls and preparation method for structural sealant | WANG SHUYI | 2015-09-23 | — | — | CN | disclosed |
| US-6518458-B1 | ((aminoiminomethyl)amino)alkane-carboxamide type in the treatment of pathologies associated with insulin resistance syndrome. | MERCK PATENT GMBH (DE) | 2003-02-11 | — | — | US | disclosed |
| EP-1140803-A1 | ((AMINOIMINOMETHYL) AMINO) ALKANECARBOXAMIDES AND THEIR APPLICATIONS IN THERAPY | MERCK PATENT GmbH (DE) | 2001-10-10 | — | — | EP | disclosed |
| WO-2000042001-A1 | ((AMINOIMINOMETHYL) AMINO) ALKANECARBOXAMIDES AND THEIR APPLICATIONS IN THERAPY | MERCK PATENT GMBH (DE) | 2000-07-20 | — | — | WO | disclosed |
| US-5459147-A | Angeotensin-antagonistic effects; hypotensive, antiischemic, and antidiabetic agents, treating glaucoma | DR. KARL THOMAE GMBH (DE) | 1995-10-17 | — | — | US | disclosed |
| US-4761416-A | ENZYME INHIBITORS, INOTROPIC AGENTS | SYNTEX (U.S.A.) INC. (US) | 1988-08-02 | — | — | US | disclosed |
| US-4739056-A | ENZYME INHIBITORS | SYNTEX (U.S.A.) INC. (US) | 1988-04-19 | — | — | US | disclosed |
| EP-0254327-A2 | N-N-disubstituted-omega-(2-amino-3-(carbonylmethyl)-3,4-dihydroquinazolinyl) oxyalkylamides and related compounds | SYNTEX (U.S.A.) INC. (US) | 1988-01-27 | — | — | EP | disclosed |
| US-4690925-A | ANTITHROMBOTIC ACTIVITY, CARDIOTONIC AGENTS | SYNTEX (U.S.A.) INC. (US) | 1987-09-01 | — | — | US | disclosed |
| EP-0153152-A2 | (2-Oxo-1,2,3,5-tetrahydroimidazo-/2,1-b/quinnazolinyl)-oxyalkylamides, their preparation, compositions containing them and their use in making medicaments | SYNTEX (U.S.A.) INC. (US) | 1985-08-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11339128-B2 | Substituted 4-amino-5-(cyclohexyloxy)quinoline-3-carboxylic acids as sweet flavor modifiers | TAS2R5, TAS2R4, TAS2R30 | EPHX1 3634/4885HPGD 2117/4885KMT2A 1024/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.